At a glance
ClinicalIndex Comparison Record- ✓Suspicion or confirmed diagnosis of primary breast cancer
- ✓Signed informed consent
- ✕Lack of signed informed consent
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
SCAN-B: The Sweden Cancerome Analysis Network - Breast Initiative
In Brief
An observational study for Breast Neoplasms. Currently recruiting, targeting 20,000 participants across 9 sites.
Signals
Detailed Summary
This study evaluates the genomic profiles of breast cancer in a prospective and population-based manner. In the first phase, breast tumors are analyzed by whole transcriptome RNA-sequencing. Gene expression profiles, mutational profiles, and transcript isoform-level data will be analyzed in the context of patient information, clinicopathological variables, and outcome, with the purpose to develop new molecular diagnostic assays for breast cancer. Additional genome-scale RNA, DNA, and protein analyses will be performed in the future.